If you need more lookups,
subscriptions start at $34 USD/month.
Jordan Baumhardt Location
Chicago, IL, US
Jordan Baumhardt Work
Investment Analyst @ (October 2025 - Present)
Vice President Corporate Development @ (January 2025 - March 2026)
Vice President Corporate Development @ (April 2024 - January 2025)
Advisor @ (April 2024 - August 2024)
Board Observer @ (July 2022 - April 2024)
Research Analyst, Principal @ (January 2023 - April 2024)
Research Analyst @ (April 2022 - January 2023)
Board Observer @ (July 2022 - April 2024)
Board Director @ (October 2022 - July 2023)
Biotech Equity Research Analyst @ (September 2021 - March 2022)
Biotech Equity Research Associate @ (June 2020 - September 2021)
PHD Molecular Biophysics @ (April 2015 - June 2020)
Project Team Lead- Office of Technology Development @ (September 2018 - December 2018)
Strategy Intern @ (October 2019 - March 2020)
Flagship Fellowship @ (June 2019 - August 2019)
Undergraduate Teaching Assistant @ (August 2014 - December 2014)
Biochemistry Research @ (August 2012 - December 2014)
Jordan Baumhardt Education
UT Southwestern Medical Center
Doctor of Philosophy (PhD) (Biomedical Sciences)
2015-2020
Illinois State University
Bachelor's degree (Biochemistry and Molecular Biology)
2011-2014
Jordan Baumhardt Skills
Protein Crystallization
Protein Purification
Protein Expression
Microsoft Office
DNA recombination
Protein Assays
Market Analysis
Jordan Baumhardt Summary
Jordan Baumhardt, based in Chicago, IL, US, is currently a Investment Analyst at BB Biotech. Jordan Baumhardt brings experience from previous roles at Lexeo Therapeutics and Zentalis Pharmaceuticals. Jordan Baumhardt holds a 2015 - 2020 Doctor of Philosophy (PhD) in Biomedical Sciences @ UT Southwestern Medical Center. With a robust skill set that includes Protein Crystallization, Protein Purification, Protein Expression, Microsoft Office, DNA recombination and more. Jordan Baumhardt has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Jordan Baumhardt?
Find contact details for 700 million professionals.